X0306 4 2017-10-12 0 0001479290 Revance Therapeutics, Inc. RVNC 0001225755 SILVERNAIL LAUREN P C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 CFO, CBO & Secretary Common Stock 2017-10-12 4 S 0 11164 26.6714 D 49006 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mrs. Silvernail. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.40 to $26.85. Mrs. Silvernail undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Gordon Ho, Attorney-in-Fact 2017-10-16